Syngene International Limited has intimated a scheduled meeting with analysts and institutional investors. The event is a physical group/one-on-one meeting and is part of the 'Healthcare Forum 2026' conference organized by Kotak.
- Event Type: Group / One-on-one Meeting (Investor Conference)
- Date and Time: September 17, 2026, at 09:00 AM. A time zone is not explicitly mentioned, but the company's location and signing timestamp suggest IST (UTC+5:30).
- Purpose: The stated purpose is participation in the Healthcare Forum 2026 investor conference.
- Management Participants: The document does not list any specific management participants or their designations.
- Presentation/Availability: The company states that the intimation details will be made available on its official website, www.syngeneintl.com. It does not mention if a presentation deck, transcript, or recording of the meeting itself will be provided.
- UPSI Statement: The company has explicitly stated that it "shall not be disclosing any Unpublished Price Sensitive Information (UPSI)" during the meeting.
No financial highlights, guidance references, or presentation summaries are included in this disclosure.
Additional Notes Section
- This is a standalone regulatory intimation letter. The document does not indicate that any attachments, such as a presentation deck or invite, were included with this filing.
- No financial data, performance figures, or strategic updates were disclosed in this announcement.
- The intimation is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.